MGB Biopharma Announces Completion of Funding Round

MGB Biopharma, a biopharmaceutical company developing a novel class of anti-infectives to address the major global problem of antibiotic resistance, today announces the completion of its latest unding round. The over-subscribed fund-raise was supported by new and existing investors, led by Archangel Investors and including Scottish Investment Bank (the investment arm of Scottish Enterprise, Scotland’s national economic development agency), Barwell and TriCapital Investors.

 

For the full article, please see here:

https://www.mgb-biopharma.com/mgb-biopharma-announces-completion-of-funding-round/